RBC Life Sciences, Inc. RBCL
0.00 USD 0.00 (+0.00%)
At close·Nov 3, 2026, 4:00 PM EST
0.0002 52-week range 0.0007
- YTD
- +75.00%
- 1 year
- +250.00%
Altman Z-Score
1.26 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.9×
P/S 0.0×
P/B 0.1×
P/FCF 99.1×
EV/EBITDA 3.2×
EV/Sales -0.0×
FCF Yield 1.0%
Gross Margin 52.8%
Operating Margin -2.6%
Net Margin -2.9%
ROE -10.6%
ROIC -8.8%
ROA -6.9%
Revenue 5.8%
Operating Income 73.5%
EPS (diluted) 0.0%
Free Cash Flow 100.2%
Current Ratio 2.3×
Quick Ratio 1.1×
Debt / Equity 0.0×
Net Debt / EBITDA 5.8×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2016-12-31